Cogent Biosciences (COGT) Research & Development (2017 - 2020)
Historic Research & Development for Cogent Biosciences (COGT) over the last 4 years, with Q4 2020 value amounting to $6.1 million.
- Cogent Biosciences' Research & Development fell 4100.83% to $6.1 million in Q4 2020 from the same period last year, while for Dec 2020 it was $25.7 million, marking a year-over-year decrease of 4111.51%. This contributed to the annual value of $269.8 million for FY2025, which is N/A changed from last year.
- According to the latest figures from Q4 2020, Cogent Biosciences' Research & Development is $6.1 million, which was down 4100.83% from $5.0 million recorded in Q3 2020.
- Cogent Biosciences' Research & Development's 5-year high stood at $12.4 million during Q1 2019, with a 5-year trough of $5.0 million in Q3 2020.
- Moreover, its 4-year median value for Research & Development was $8.7 million (2017), whereas its average is $8.6 million.
- In the last 5 years, Cogent Biosciences' Research & Development surged by 5233.36% in 2019 and then plummeted by 5169.07% in 2020.
- Cogent Biosciences' Research & Development (Quarter) stood at $7.6 million in 2017, then soared by 42.36% to $10.8 million in 2018, then decreased by 3.82% to $10.4 million in 2019, then tumbled by 41.01% to $6.1 million in 2020.
- Its Research & Development was $6.1 million in Q4 2020, compared to $5.0 million in Q3 2020 and $5.1 million in Q2 2020.